Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of INR 176.27 billion. The enterprise value is 146.54 billion.
Important Dates
The last earnings date was Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Jul 17, 2026 |
Share Statistics
Pfizer has 45.75 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | 45.75M |
| Shares Outstanding | 45.75M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 17.64% |
| Float | 15.11M |
Valuation Ratios
The trailing PE ratio is 20.51 and the forward PE ratio is 20.87.
| PE Ratio | 20.51 |
| Forward PE | 20.87 |
| PS Ratio | 6.64 |
| PB Ratio | 4.02 |
| P/TBV Ratio | 4.58 |
| P/FCF Ratio | 25.61 |
| P/OCF Ratio | 24.23 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 15.07, with an EV/FCF ratio of 21.29.
| EV / Earnings | 17.04 |
| EV / Sales | 5.52 |
| EV / EBITDA | 15.07 |
| EV / EBIT | 15.99 |
| EV / FCF | 21.29 |
Financial Position
The company has a current ratio of 5.87, with a Debt / Equity ratio of 0.04.
| Current Ratio | 5.87 |
| Quick Ratio | 5.18 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.20 |
| Debt / FCF | 0.29 |
| Interest Coverage | 102.79 |
Financial Efficiency
Return on equity (ROE) is 20.87% and return on invested capital (ROIC) is 52.24%.
| Return on Equity (ROE) | 20.87% |
| Return on Assets (ROA) | 11.57% |
| Return on Invested Capital (ROIC) | 52.24% |
| Return on Capital Employed (ROCE) | 19.88% |
| Weighted Average Cost of Capital (WACC) | 5.09% |
| Revenue Per Employee | 21.34M |
| Profits Per Employee | 6.91M |
| Employee Count | 1,244 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.10 |
Taxes
In the past 12 months, Pfizer has paid 3.01 billion in taxes.
| Income Tax | 3.01B |
| Effective Tax Rate | 25.93% |
Stock Price Statistics
The stock price has decreased by -23.09% in the last 52 weeks. The beta is 0.16, so Pfizer's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -23.09% |
| 50-Day Moving Average | 3,883.58 |
| 200-Day Moving Average | 4,525.29 |
| Relative Strength Index (RSI) | 49.54 |
| Average Volume (20 Days) | 38,375 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pfizer had revenue of INR 26.54 billion and earned 8.59 billion in profits. Earnings per share was 187.86.
| Revenue | 26.54B |
| Gross Profit | 16.65B |
| Operating Income | 9.16B |
| Pretax Income | 11.60B |
| Net Income | 8.59B |
| EBITDA | 9.38B |
| EBIT | 9.16B |
| Earnings Per Share (EPS) | 187.86 |
Full Income Statement Balance Sheet
The company has 31.70 billion in cash and 1.97 billion in debt, with a net cash position of 29.73 billion or 649.88 per share.
| Cash & Cash Equivalents | 31.70B |
| Total Debt | 1.97B |
| Net Cash | 29.73B |
| Net Cash Per Share | 649.88 |
| Equity (Book Value) | 43.85B |
| Book Value Per Share | 958.56 |
| Working Capital | 33.39B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 7.27 billion and capital expenditures -393.30 million, giving a free cash flow of 6.88 billion.
| Operating Cash Flow | 7.27B |
| Capital Expenditures | -393.30M |
| Depreciation & Amortization | 221.00M |
| Net Borrowing | -400.80M |
| Free Cash Flow | 6.88B |
| FCF Per Share | 150.34 |
Full Cash Flow Statement Margins
Gross margin is 62.72%, with operating and profit margins of 34.50% and 32.38%.
| Gross Margin | 62.72% |
| Operating Margin | 34.50% |
| Pretax Margin | 43.71% |
| Profit Margin | 32.38% |
| EBITDA Margin | 35.34% |
| EBIT Margin | 34.50% |
| FCF Margin | 25.91% |
Dividends & Yields
This stock pays an annual dividend of 75.00, which amounts to a dividend yield of 1.95%.
| Dividend Per Share | 75.00 |
| Dividend Yield | 1.95% |
| Dividend Growth (YoY) | -54.55% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 39.75% |
| FCF Payout Ratio | 49.89% |
| Buyback Yield | -0.00% |
| Shareholder Yield | 1.95% |
| Earnings Yield | 4.88% |
| FCF Yield | 3.90% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Analyst Forecast
The average price target for Pfizer is 5,321.60, which is 38.12% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 5,321.60 |
| Price Target Difference | 38.12% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 7.13% |
| EPS Growth Forecast (3Y) | 10.25% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |